CSPC PHARMACEUT.GR. ADR4 Net Asset Quality Index
CSPC PHARMACEUT.GR. ADR4 net asset quality index. CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Net Asset Quality Index of 70.4% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €56.02 Billion minus total liabilities of €16.59 Billion yields net assets of €39.43 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of CSPC PHARMACEUT.GR. ADR4 for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of CSPC PHARMACEUT.GR. ADR4 (2021–2025)
Net asset quality index of CSPC PHARMACEUT.GR. ADR4 from 2021 to 2025. This chart shows how CSPC PHARMACEUT.GR. ADR4's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the index stands at 70.4%, representing net assets of €39.43 Billion against total assets of €56.02 Billion EUR. Check CVGU tangible net assets ratio to evaluate the tangible quality of the company's equity base.
CSPC PHARMACEUT.GR. ADR4 Net Asset Quality Index by Year (2021–2025)
CSPC PHARMACEUT.GR. ADR4 net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for CSPC PHARMACEUT.GR. ADR4 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of CSPC PHARMACEUT.GR. ADR4.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.0% | €34.55 Billion | €46.70 Billion | €12.15 Billion | ▼ -2.3 pp |
| 2024 | 76.3% | €33.87 Billion | €44.39 Billion | €10.52 Billion | ▲ +0.6 pp |
| 2023 | 75.7% | €35.02 Billion | €46.28 Billion | €11.26 Billion | ▼ -0.1 pp |
| 2022 | 75.8% | €31.64 Billion | €41.77 Billion | €10.13 Billion | ▼ -1.5 pp |
| 2021 | 77.2% | €26.83 Billion | €34.74 Billion | €7.91 Billion | — |